Ringworm Treatment
Ishancare Ringworm Treatment
Shenzhen Ishan Technology Co., Ltd
Human Otc Drug
NDC 73076-126Ringworm Treatment also known as Ishancare Ringworm Treatment is a human otc drug labeled by 'Shenzhen Ishan Technology Co., Ltd'. National Drug Code (NDC) number for Ringworm Treatment is 73076-126. This drug is available in dosage form of Cream. The names of the active, medicinal ingredients in Ringworm Treatment drug includes Clotrimazole - 1 g/100g . The currest status of Ringworm Treatment drug is Active.
Drug Information:
| Drug NDC: | 73076-126 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Ringworm Treatment |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Ishancare Ringworm Treatment |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Shenzhen Ishan Technology Co., Ltd |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Cream |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | CLOTRIMAZOLE - 1 g/100g
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | TOPICAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | UNAPPROVED HOMEOPATHIC |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 01 Dec, 2022 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 22 Dec, 2025 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | Shenzhen Ishan Technology Co., Ltd
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| NUI: | N0000175487
M0002083
|
| Unique identifier applied to a drug concept within the National Drug File Reference Terminology (NDF-RT). |
| UNII: | G07GZ97H65
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
| Pharmacologic Class EPC: | Azole Antifungal [EPC]
|
| Established pharmacologic class associated with an approved indication of an active moiety (generic drug) that the FDA has determined to be scientifically valid and clinically meaningful. Takes the form of the pharmacologic class, followed by `[EPC]` (such as `Thiazide Diuretic [EPC]` or `Tumor Necrosis Factor Blocker [EPC]`. |
| Pharmacologic Class CS: | Azoles [CS]
|
| Chemical structure classification of the drug product’s pharmacologic class. Takes the form of the classification, followed by `[Chemical/Ingredient]` (such as `Thiazides [Chemical/Ingredient]` or `Antibodies, Monoclonal [Chemical/Ingredient]. |
| Pharmacologic Class: | Azole Antifungal [EPC]
Azoles [CS]
|
| These are the reported pharmacological class categories corresponding to the SubstanceNames listed above. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 73076-126-01 | 50 g in 1 TUBE (73076-126-01) | 01 Dec, 2022 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Uses: cures most ringworm, athlete's foot and jock itch. relieves itching, burning, irritation and discomforts which may accompany these conditions
Product Elements:
Ringworm treatment ishancare ringworm treatment sophora flavescens root dictamnus dasycarpus root phellodendron chinense whole bassia scoparia fruit cnidium monnieri fruit clotrimazole clotrimazole stellera chamaejasme whole menthol
Indications and Usage:
Directions: * wash affected area and dry thoroughly * apply a thin layer ishancare over affected area twice daily (morning and night) or as directed by a doctor. * for athlete's foot, pay special attention to spaces between toes; wear well fitting, ventilated shoes, change shoes and socks at least once daily. * for athlete's foot and ringworm, use daily for 4 weeks. * for jock itch, use daily for 2 weeks. * for fungal infection on toe use brush applicator to apply under nail and around cuticle. this product is not proven to be effective on scalp or nails.
Warnings:
Warning: for external use only.
Dosage and Administration:
Dosage & administration
Stop Use:
Stop use if irritation occurs & condition persists or there is no improvement of athlete's foot or ringworm within 4 weeks or jock itch with 2 weeks
Package Label Principal Display Panel:
Lable label